December 27, 2013 article Postoperative Complications Reduce Adjuvant Chemotherapy Use in Resectable Pancreatic Cancer Annals of Surgery DOI: 10.1097/sla.0000000000000378 OpenAlex Authors 0 Author list not loaded yet. Cited by 8 stored of 456 Search Sort Most cited Newest Oldest Patent citations Title Any typearticle review book-chapter conference-paper preprint dissertation book dataset other Any fieldAgricultural and Biological Sciences Arts and Humanities Biochemistry, Genetics and Molecular Biology Business, Management and Accounting Chemical Engineering Chemistry Computer Science Decision Sciences Dentistry Earth and Planetary Sciences Economics, Econometrics and Finance Energy Engineering Environmental Science Health Professions Immunology and Microbiology Materials Science Mathematics Medicine Neuroscience Nursing Pharmacology, Toxicology and Pharmaceutics Physics and Astronomy Psychology Social Sciences Veterinary Open access Long-term oncological outcomes following algorithm-based care versus usual care for the early recognition and management of complications after pancreatic resection: a post-hoc analysis of a nationwide, stepped-wedge cluster-randomised trial 2026 The Lancet. Gastroenterology & hepatology article Medicine Pancreatic and Hepatic Oncology Research Open access 2 citations Predictive value of baseline serum carbohydrate antigen 19-9 level on treatment effect of neoadjuvant chemoradiotherapy in patients with resectable and borderline resectable pancreatic cancer in two randomized trials 2023 British journal of surgery article Medicine Pancreatic and Hepatic Oncology Research Open access 15 citations Impact of complications after resection of pancreatic cancer on disease recurrence and survival, and mediation effect of adjuvant chemotherapy: nationwide, observational cohort study 2023 BJS Open article Medicine Pancreatic and Hepatic Oncology Research Open access 34 citations Risk Models for Developing Pancreatic Fistula After Pancreatoduodenectomy 2023 Annals of Surgery article Medicine Pancreatic and Hepatic Oncology Research Open access 30 citations Neoadjuvant Chemoradiotherapy Versus Upfront Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Long-Term Results of the Dutch Randomized PREOPANC Trial 2022 Journal of Clinical Oncology article Medicine Pancreatic and Hepatic Oncology Research Open access 738 citations Preoperative predictors for early and very early disease recurrence in patients undergoing resection of pancreatic ductal adenocarcinoma 2021 HPB article Medicine Pancreatic and Hepatic Oncology Research Open access 44 citations Total neoadjuvant FOLFIRINOX versus neoadjuvant gemcitabine-based chemoradiotherapy and adjuvant gemcitabine for resectable and borderline resectable pancreatic cancer (PREOPANC-2 trial): study protocol for a nationwide multicenter randomized controlled trial 2021 BMC Cancer article Medicine Pancreatic and Hepatic Oncology Research Open access 168 citations Preoperative Chemoradiotherapy Versus Immediate Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Results of the Dutch Randomized Phase III PREOPANC Trial 2020 Journal of Clinical Oncology article Medicine Pancreatic and Hepatic Oncology Research Open access cited by 1 patent 1,106 citations 8 results References 0